1-6 of 6
Elisa Seneca
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy of Nilotinib in EARLY Chronic PHASE CML Patients WHO Have Suboptimal Cytogenetic or Molecular Response to Imatinib. A Multicentric Retrospective Study

Luigia Luciano, MD, Elisa Seneca, MD, Mario Annunziata, MD, Luca Pezzullo, MD, Paolo Danise, MD, Ursula Sessa, MD, Fausto Palmieri, MD, Mariolina Iovine, MD, Roberto Vallone, MD, Fabrizio Pane
Journal: Blood
Blood (2012) 120 (21): 4454.
https://doi.org/10.1182/blood.V120.21.4454.4454
Published: 2012
Journal Articles

From Renal Siderosis Due to Perpetual Hemosiderinuria to Possible Liver Overload Due to Extravascular Hemolysis: Changes in Iron Metabolism in Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients On Eculizumab.

Antonio M. Risitano, MD, PhD, Elisa Seneca, Ludovica Marando, Massimo Imbriaco, Ernesto Soscia, Francesca Soscia, Laura Micol Pizzuti, Luca Malcovati, Susanna Fenu, Anna Paola Iori, Rosario Notaro, M.D., Margherita Matarazzo, Bruno Rotoli
Journal: Blood
Blood (2009) 114 (22): 4031.
https://doi.org/10.1182/blood.V114.22.4031.4031
Published: 2009
Journal Articles

Complement fraction 3 binding on erythrocytes as additional mechanism of disease in paroxysmal nocturnal hemoglobinuria patients treated by eculizumab

Antonio M. Risitano, Rosario Notaro, Ludovica Marando, Bianca Serio, Danilo Ranaldi, Elisa Seneca, Patrizia Ricci, Fiorella Alfinito, Andrea Camera, Giacomo Gianfaldoni, Angela Amendola, Carla Boschetti, Eros Di Bona, Giorgio Fratellanza, Filippo Barbano, Francesco Rodeghiero, Alberto Zanella, Anna Paola Iori, Carmine Selleri, Lucio Luzzatto, Bruno Rotoli
Journal: Blood
Blood (2009) 113 (17): 4094–4100.
https://doi.org/10.1182/blood-2008-11-189944
Published: 2009
Journal Articles

Subcutaneous Alemtuzumab Is a Safe and Effective Treatment for Global or Single-Lineage Immune-Mediated Marrow Failures: a Survey from the EBMT-WPSAA

Antonio M. Risitano, MD, PhD, Elisa Seneca, Ludovica Marando, Bianca Serio, Carmine Selleri, Giulia Scalia, Luigi Del Vecchio, MD, Annapaola Iori, M.D., Alexander Kulagin, Sebastien Maury, Joerg Halter, Vikas Gupta, MD, MRCP, MRCPath, Andrea Bacigalupo, MD, Gerard Socié, Andre Tichelli, Judith Marsh, Hubert Schrezenmeier, Jakob R. Passweg, MD, MS, Bruno Rotoli
Journal: Blood
Blood (2008) 112 (11): 1042.
https://doi.org/10.1182/blood.V112.11.1042.1042
Published: 2008
Journal Articles

C3-Mediated Extravascular Hemolysis as Additional Mechanism of Disease in Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients Treated by the Complent Inhibitor Eculizumab

Antonio M. Risitano, MD, PhD, Ludovica Marando, Danilo Ranaldi, Elisa Seneca, Bianca Serio, Giacomo Gianfaldoni, Elisabetta Antonioli, Filippo Milano, Angela Amendola, Carla Boschetti, Wilma Barcellini, Eros Di Bona, Angelo Michele Carella, Filippo Barbano, Silvana Bonfigli, Silvana Capalbo, Francesco Fabbiano, Stefano Pulini, Antonio Marino, MD, Francesco Pietrogrande, Franco Iuliano, Francesco Rodeghiero, Alberto Zanella, M.D., Annapaola Iori, M.D., Rosario Notaro, M.D., Lucio Luzzatto, Bruno Rotoli
Journal: Blood
Blood (2008) 112 (11): 485.
https://doi.org/10.1182/blood.V112.11.485.485
Published: 2008
Journal Articles

Hemoglobin normalization after splenectomy in a paroxysmal nocturnal hemoglobinuria patient treated by eculizumab

Antonio M. Risitano, Ludovica Marando, Elisa Seneca, Bruno Rotoli
Journal: Blood
Blood (2008) 112 (2): 449–451.
https://doi.org/10.1182/blood-2008-04-151613
Published: 2008